Xeltis has raised €20.5m ($23.3m), setting the vascular graft specialist up with proceeds to further its preparation for US market commercialisation and help solidify a European ...

Boston Scientific is initiating a global restructuring programme in an effort to drive “sustained cost efficiencies” and support continued growth that it concedes will also re ...

Magnendo has closed an $18m Series A financing round to further develop its magnetic robotic navigation platform for neuro-endovascular procedures.

Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a 12% uptick YoY.

Under the deal, Personalis’ minimal residual disease (MRD) test will be integrated into Tempus’ broader oncology portfolio.

Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its 2026 revenue growth outlook.

GE HealthCare's tool is intended to streamline imaging workflow collaboration between different specialist teams in areas such as oncology.

Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.

Affinity Technologies has collaborated with Pictor to develop and commercialise new diagnostic tests for asthma and COPD.

GE HealthCare and Catholic Health have signed a 10-year strategic alliance valued at around $500m, aimed at expanding access to precision diagnostics, advanced imaging, and AI-supported technology ...

British Business Bank has previously co-invested in EQT's fund portfolio companies Phagenesis and Cyted Health.